Victory Capital Management Inc Albireo Pharma, Inc. Transaction History

Victory Capital Management Inc

$98.4 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$18.54 - $37.29 $414,925 - $834,550	22,380 New	22,380 $444,000
Q3 2021 Nov 02, 2021	SELL	$27.36 - $35.98 $882,907 - $1.16 Million	-32,270 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$28.9 - $36.87 $57,800 - $73,740	-2,000 Reduced 5.84%	32,270 $1.14 Million
Q1 2021 May 04, 2021	SELL	$32.03 - $42.85 $50,927 - $68,131	-1,590 Reduced 4.43%	34,270 $1.21 Million
Q4 2020 Feb 01, 2021	SELL	$31.56 - $42.16 $198,512 - $265,186	-6,290 Reduced 14.92%	35,860 $1.35 Million

Q3 2020 Nov 09, 2020	SELL	$23.19 - $41.61 $102,499 - $183,916	-4,420 Reduced 9.49%	42,150 $1.41 Million
Q2 2020 Aug 07, 2020	SELL	$14.82 - $29.92 $1.51 Million - $3.04 Million	-101,768 Reduced 68.61%	46,570 $1.23 Million
Q1 2020 May 04, 2020	SELL	$11.67 - $27.23 $42,152 - $98,354	-3,612 Reduced 2.38%	148,338 $2.43 Million
Q4 2019 Feb 06, 2020	SELL	$16.92 - $28.96 $10,964 - $18,766	-648 Reduced 0.42%	151,950 $3.86 Million
Q4 2019 Feb 04, 2020	SELL	$16.92 - $28.96 $409,125 - $700,252	-24,180 Reduced 13.68%	152,598 $3.46 Million
Q3 2019 Nov 12, 2019	BUY	$20.0 - $31.88 $2.34 Million - $3.74 Million	117,178 Added 196.61%	176,778 $3.54 Million
Q2 2019 Aug 15, 2019	SELL	$30.67 - $37.86 $116,852 - $144,246	-3,810 Reduced 6.01%	59,600 $1.92 Million
Q1 2019 May 03, 2019	SELL	$22.22 - $32.21 $195,091 - $282,803	-8,780 Reduced 12.16%	63,410 $2.04 Million
Q4 2018 Feb 05, 2019	BUY	$20.9 - $32.57 $433,465 - $675,501	20,740 Added 40.31%	72,190 $1.77 Million
Q3 2018 Nov 01, 2018	SELL	$29.29 - $36.87 $82,597 - $103,973	-2,820 Reduced 5.2%	51,450 $1.7 Million
Q2 2018 Aug 02, 2018	SELL	$28.9 - $37.31 $89,879 - $116,034	-3,110 Reduced 5.42%	54,270 $1.93 Million
Q1 2018 May 04, 2018	BUY	$26.78 - $39.35 $1.54 Million - $2.26 Million	57,380 New	57,380 $1.87 Million

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account